Non artritic anterior ischemic opthic neropathy. Ischaemic optic neuropathy
Conditions
Interventions
Intervention 1: single sub-tenon injection of 40 mg methyle prednisolone. Intervention 2: Simulated injection as placebo.
Treatment - Drugs
Placebo
single sub-tenon injection of 40 mg methyle prednisolone
Simulated injection as placebo
Sponsors
Vise chanceller for research, Isfahan University of medical sciences
Eligibility
Sex/Gender
All
Age
37 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: recent onset of non arthritic anterior ischemic optic neuropathy, history of acute visual loss, optic disc edema, afferent papillary defect, andangiographic picture, no apparent other ocular or systemic disease related to the acute visual loss Exclusion criteria: presence of IOP of more than 21 mmhg, history of glaucoma, ocular hypertention, abnormal visual field in the sound eye, high ESR, any additional intervention during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity. Timepoint: before the intervention and at 2 weeks, 4 weeks, 6 weeks, and 8 weeks steps of follow up after the intervention. Method of measurement: Snellen chart.;Optic disc edema. Timepoint: before the intervention and at 2 weeks, 4 weeks, 6 weeks, and 8 weeks steps of follow up after the intervention. Method of measurement: Slit lamp ophthalmoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plotting the visual field. Timepoint: before the intervention and at 8 weeks steps of follow up after the intervention. Method of measurement: Humphry Automated perimeter. | — |
Countries
Iraq
Contacts
Public ContactHamid Fesharaki
Esfahan Eye Research Center
Outcome results
None listed